• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cara Therapeutics Inc

+ Add to Watchlist

CARA:US

10.8300 USD 0.1100 1.01%

As of 20:10:00 ET on 01/23/2015.

Snapshot for Cara Therapeutics Inc (CARA)

Open: 10.9100 Day's Range: 10.7500 - 11.0400 Volume: 169,769
Previous Close: 10.9400 52wk Range: 7.5300 - 23.2500 1-Yr Rtn: -

Stock Chart for CARA

No chart data available.
  • CARA:US 10.8300
  • 1D
  • 1M
  • 1Y
10.9400
Interactive CARA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CARA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.1700
Est. EPS (USD) (12/2014) -0.9630
Est. PEG Ratio -
Market Cap (M USD) 246.69
Shares Outstanding (M) 22.78
30 Day Average Volume 187,495
Price/Book (mrq) 4.4582
Price/Sale (ttm) 32.2465
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CARA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CARA

Cara Therapeutics, Inc. develops therapeutics. The Company offers novel drugs for the treatment of human diseases associated with pain and inflammation. Cara Therapeutics serves customers in the United States.

Derek ChalmersPresident/CEO/Co-FounderJosef C SchoellChief Financial Officer
Joseph StaufferChief Medical OfficerFrederique MenzaghiVP:R&D/Co-Founder
More Company Profile & Key Executives for CARA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil